IL2RG and breast cancer: We orthotopically injected human breast cancer cells (SUM159PT) to mammary fat pads of NOD‐Scid IL2Rg‐null (NSG) mice, allowed tumors to develop to ~250 mm3, and then systemically injected 60 U ASNase per day for 5 consecutive days.